Research Article
A Novel Inflammation-Based Stage (I Stage) in Patients with Resectable Esophageal Squamous Cell Carcinoma
Table 4
Multivariate analyses for patients with ESCC.
| | HR (95% CI) | value |
| Tumor length (cm) | | 0.603 | ≤3 | 1.000 | | >3 | 1.075 (0.818–1.412) | | Vessel involvement | | 0.742 | Negative | 1.000 | | Positive | 1.060 (0.747–1.505) | | Perineural invasion | | 0.077 | Negative | 1.000 | | Positive | 1.341 (0.968–1.857) | | TNM stage | | <0.001 | I | 1.000 | | II | 1.586 (1.048–2.400) | 0.029 | III | 2.220 (1.456–3.384) | <0.001 | I stage | | <0.001 | I0 | 1.000 | | I1 | 1.543 (1.076–2.214) | 0.018 | I2 | 2.356 (1.602–3.466) | <0.001 | I3 | 3.594 (2.363–5.467) | <0.001 | CRP (mg/L) | | 0.493 | ≤10.0 | 1.000 | | >10.0 | 1.151 (0.770–1.719) | | NLR | | 0.786 | ≤3.5 | 1.000 | | >3.5 | 1.050 (0.740–1.488) | | PLR | | 0.065 | ≤150 | 1.000 | | >150 | 1.440 (0.978–2.121) | |
|
|